Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Mach7 Technologies Limited is an Australia-based medical imaging software company that operates in the healthcare information technology and medical imaging informatics industries. The company specializes in enterprise imaging solutions that enable healthcare providers to manage, store, access, and share medical imaging data across clinical departments and care settings. Its core offerings support radiology, cardiology, pathology, and other image-intensive specialties, with a focus on interoperability and vendor-neutral data management.
The company’s primary revenue drivers are software licensing, subscription-based software-as-a-service (SaaS) contracts, and related maintenance and professional services. Mach7 serves hospitals, integrated delivery networks, academic medical centers, and large healthcare systems, primarily in developed healthcare markets. Its strategic positioning centers on vendor-neutral archive (VNA) and enterprise imaging platform capabilities, which allow healthcare providers to consolidate imaging data from multiple legacy systems. Founded in Australia in 2006, Mach7 has evolved through organic product development and targeted acquisitions to become a specialized global provider of enterprise imaging solutions.
Business Operations
Mach7 generates revenue through its enterprise imaging software platform, which includes VNA, image lifecycle management, and advanced data migration tools. These solutions are typically sold under long-term contracts, combining recurring software subscriptions with implementation and support services. The company operates primarily under a direct sales model, complemented by channel and technology partners within the healthcare IT ecosystem.
Operations span both domestic and international markets, with significant activity in North America, which represents the company’s largest revenue base. Mach7 controls proprietary imaging software technologies designed to integrate with electronic health records (EHRs), picture archiving and communication systems (PACS), and cloud infrastructure. The company has expanded its operational capabilities through acquisitions, including Client Outlook Inc. and eUnity, which strengthened its data migration, cardiology imaging, and enterprise workflow capabilities.
Strategic Position & Investments
Mach7’s strategic direction emphasizes growth in enterprise-wide imaging adoption, cloud-enabled deployment models, and replacement of aging PACS and siloed imaging systems. The company has pursued acquisitions to deepen its technical capabilities and expand its addressable market, notably through the acquisition of Client Outlook Inc., which added advanced data migration tools, and eUnity, which enhanced its cardiology and multi-specialty imaging offerings.
The company invests in interoperability standards, imaging data governance, and scalable architectures aligned with broader healthcare digital transformation initiatives. Mach7’s platform strategy targets large healthcare systems seeking to reduce complexity, improve clinical access to imaging data, and lower long-term IT costs. Emerging focus areas include cloud-hosted imaging environments and expanded support for non-DICOM imaging content.
Geographic Footprint
Mach7 is headquartered in Australia, with significant operational and commercial presence in North America, particularly the United States, which is its primary market. The company also maintains operations and customer deployments in Europe and parts of the Asia-Pacific region, reflecting a multinational customer base among large healthcare providers.
Internationally, Mach7’s influence is concentrated in developed healthcare systems with complex imaging environments and strong demand for enterprise imaging solutions. Sales, implementation, and support functions are distributed across multiple regions to support global customers, with a strategic emphasis on expanding penetration in the U.S. healthcare market.
Leadership & Governance
Mach7 is led by an executive team with experience in healthcare IT, medical imaging, and enterprise software. The leadership’s strategic vision emphasizes disciplined growth, recurring revenue expansion, and long-term partnerships with healthcare providers, supported by continued investment in product innovation and interoperability.
Key executives include:
- Mike Lampron – Chief Executive Officer
- Andrew Selwyn – Chief Financial Officer
- Sean Casey – Chief Technology Officer
- Chris Lawton – Chief Revenue Officer
- Jon DeVries – Chief Customer Officer
The company is publicly listed on the Australian Securities Exchange and also trades in the U.S. over-the-counter market, operating under governance and disclosure standards applicable to publicly traded entities.